Successful treatment of osimertinib-resistant EGFR-mutant NSCLC with acquired BRAF V600E mutation using triple combination therapy: a case report with pathological confirmation. [PDF]
World J Surg OncolLin M, Chen X, Lin F, Yang Y.
europepmc +1 more source
Advances in targeting KRAS mutations: A promising approach for the treatment of non‑small cell lung cancer (Review). [PDF]
Oncol RepSharma U, Song J, Kandu H, Zhu Y, Dai Z.
europepmc +1 more source
Reprogramming the Apoptosis-Autophagy Axis in Glioblastoma: The Central Role of the Bcl-2:Beclin-1 Complex and Survival Signalling Networks. [PDF]
CellsChristoff M +3 more
europepmc +1 more source
Targeted drug conjugates and molecular mechanisms in overcoming lung cancer drug resistance. [PDF]
Discov OncolYe L +7 more
europepmc +1 more source
Molecular Alterations and Pathways in Intrahepatic Cholangiocarcinoma: Available Evidence and New Perspectives. [PDF]
Int J Mol SciAstore M +9 more
europepmc +1 more source
Disrupting resistance: novel therapeutic approaches to combat multidrug resistance in fusion-negative rhabdomyosarcoma. [PDF]
Cancer Drug ResistCodenotti S +9 more
europepmc +1 more source
Targeted protein degradation in oncology: novel therapeutic opportunity for solid tumours? [PDF]
Mol OncolHerbel N, Postel-Vinay S.
europepmc +1 more source
Pancreatic cancer: molecular pathogenesis and emerging therapeutic strategies. [PDF]
Signal Transduct Target TherRozengurt E, Eibl G.
europepmc +1 more source